Research

Energy balance

Metformin protects against cardiac ischemia-reperfusion injury and improves heart failure outcomes post-MI by activating AMPK, which promotes glycolysis and prevents mitochondrial permeability transition pore (mPTP) opening.

If you have had a heart attack, metformin (even in low doses) may help protect your heart muscle from further damage by improving energy use in heart cells. This benefit extends to non-diabetic heart failure patients as well, improving heart pumping function.

ModerateSupportsMEDIUM confidence
Several studies have suggested that metformin protects against cardiac IRI through the activation of AMPK [52–54]. Activation of AMPK promotes glycolysis and protects myocyte viability through closure of the mitochondrial permeability transition pore (mPTP)... metformin protects the heart against IRI through AMPK–eNOS signaling
Joseph Zhou et al. · International Journal of Molecular Sciences · 2018

Why this rating

Strong animal data and some human observational data; mechanism is well-described.

Source

Metformin: An Old Drug with New Applications

Joseph Zhou et al. · International Journal of Molecular Sciences · 2018

DOI 10.3390/ijms19102863

narrative_reviewCited 229×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →